Christine Jenkins's Publications

About Christine Jenkins's Publications

Program Head, Respiratory
  • Professor of Respiratory Medicine, Faculty of Medicine, UNSW Sydney
  • Clinical Professor, Concord Clinical School, University of Sydney
  • AM,
  • MD,
  • FRACP,
  • FThor ,
  • Soc ,
  • FAAHMS

  • Health status in the TORCH study of COPD: treatment efficacy and other determinants of change

    Respiratory Research Date published:

  • Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps

    Respiratory Research Date published:

  • What's in a name? Brand name confusion and generic medicines

    Medical Journal of Australia Date published:

  • Unmet Needs of Older People with Asthma: Cross-Sectional Survey

    Journal of Asthma Date published:

  • Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study

    Vaccine Date published:

  • Improving paediatric asthma outcomes in primary health care: a randomised controlled trial

    Medical Journal of Australia Date published:

  • COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population

    BMC Public Health Date published:

  • Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study

    European Respiratory Journal Date published:

  • A new perspective on optimal care for patients with COPD

    Primary Care Respiratory Journal Date published:

  • Factor Analysis On 16 Clinical And Demographic Variables In More Than 6000 COPD Patients

    A14. DEFINING CLINICAL PHENOTYPES OF COPD Date published:

  • Effect Of Budesonide/Formoterol Treatment On Dominant Predictors Of Exacerbations In Patients With COPD

    C101. NEW INSIGHTS INTO ALPHA-1-ANTITRYPSIN DEFICIENCY AND OUTCOMES FOLLOWING COPD EXACERBATIONS Date published:

  • Identification Of Baseline Characteristics That Predict Future Risk Of Exacerbations In COPD Patients

    C101. NEW INSIGHTS INTO ALPHA-1-ANTITRYPSIN DEFICIENCY AND OUTCOMES FOLLOWING COPD EXACERBATIONS Date published:

  • The Prevalence Of Reported Cardiovascular Disease In Subjects With Non-Reversible Airways Obstruction - Findings From The Multi-Center Population-Based Burden Of Obstructive Lung Disease (BOLD) Study

    D18. AIR POLLUTION AND CARDIOVASCULAR DISEASE Date published:

  • Effect of different asthma treatments on risk of cold-related exacerbations

    European Respiratory Journal Date published:

  • Sex Differences in Mortality and Clinical Expressions of Patients with Chronic Obstructive Pulmonary Disease

    American Journal of Respiratory and Critical Care Medicine Date published:

  • FluCAN 2009: initial results from sentinel surveillance for adult influenza and pneumonia in eight Australian hospitals

    Medical Journal of Australia Date published: